Drug interactions resource: COVID-19
Drug interactions resource for drugs under investigation against COVID-19
A COVID-19 drug interactions website has been launched by the University of Liverpool (www.covid19-druginteractions.org). It is designed to support prescribers managing drug interactions with investigational medicinal products (both licensed products being used off-label and unlicensed products) being tested against COVID-19 within clinical trials. This is available for free and does not require registration. More information is available in this press release.
Experimental COVID-19 therapies are not licensed to treat COVID-19 and should only be prescribed as part of a clinical trial and within strict trial protocol. An information sheet about key drug interactions will be placed in patients notes by the research teams as part of the enrolment process.
This online resource provides additional drug interaction information to that available within clinical trial protocols and is of particular importance when treating patients with multiple co-morbidities. These patients may be started on new medicines during participation in the clinical trial, or re-started on long-term medicines that were initially withheld while participating in a COVID-19 clinical trial.
Published 10/06/2020. Medicines Update blogs are correct at the time of publication.